ALEXANDRIA, Va., March 3 -- United States Patent no. 12,564,642, issued on March 3, was assigned to SANOFI (Paris).

"CEACAM5 antibody-drug conjugate formulation" was invented by Jean-Rene Authelin (Paris), Fethi Bensaid (Paris), Audrey Bonestebe (Paris), Sylvain Huille (Paris), Marie Leman (Paris) and Lucie Manache-Alberici (Paris).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are stabilized formulations of the human carcinoembryonic antigen-related cell adhesion molecule 5 (hCEACAM5)-targeted antibody-drug conjugate huMAb2-3-SPDB-DM4, as well as methods for making and using same."

The patent was filed on Nov. 9, 2021, under Application No. 17/522,443.

*For further information, including images, c...